Kingfisher Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-17,416
Closed -$4.7M 191
2021
Q4
$4.7M Buy
17,416
+389
+2% +$96.3K 1.09% 28
2021
Q3
$4.12M Buy
17,027
+308
+2% +$77.6K 1.07% 26
2021
Q2
$3.96M Buy
16,719
+382
+2% +$87K 1.01% 31
2021
Q1
$3.58M Buy
16,337
+679
+4% +$136K 1% 24
2020
Q4
$2.74M Buy
15,658
+250
+2% +$43.2K 0.83% 43
2020
Q3
$2.49M Buy
15,408
+990
+7% +$157K 0.9% 34
2020
Q2
$2.06M Buy
14,418
+119
+0.8% +$16.5K 0.91% 32
2020
Q1
$1.55M Buy
+14,299
New +$2.06M 0.8% 42

Other funds holding LH

Kingfisher Capital's LH Position: Q1 2022 in Review

Kingfisher Capital sold out of Labcorp (LH) in Q1 2022, closing a stake of 17,416 shares — an estimated $4.7M sold.

Kingfisher Capital first reported a position in LH in Q1 2020 and held it in 8 quarters. The position peaked at $4.7M in Q4 2021. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

  • Kingfisher Capital reported no remaining Labcorp position as of Q1 2022 after selling out during the quarter.
  • Kingfisher Capital sold 17,416 Labcorp shares in Q1 2022, an estimated $4.7M.
  • Kingfisher Capital first reported a position in Labcorp in Q1 2020 and held it in 8 quarters.
  • Kingfisher Capital's Labcorp position peaked at $4.7M in Q4 2021.
  • 1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Kingfisher Capital's 13F filing for Q1 2022, filed 10 May 2022.